Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$18,298,538
+$1,217,316 QoQ
Shares Held
72,050
+3.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#781
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. JNJ ranks #1 (41.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,298,538 | 72,050 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $17,081,222 | 69,879 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $14,371,228 | 69,443 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $12,453,734 | 67,165 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,356,755 | 67,802 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $11,371,317 | 68,568 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $10,222,464 | 70,685 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $9,553,112 | 58,948 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,886,381 | 60,799 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,981,472 | 63,098 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $10,147,504 | 64,741 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $10,416,715 | 66,881 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,429,299 | 81,134 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $12,530,200 | 80,840 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $13,898,115 | 78,676 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,936,151 | 79,188 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,920,334 | 78,420 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,014,107 | 79,073 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $12,586,133 | 73,573 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,706,004 | 72,483 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $11,206,767 | 68,027 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $11,153,284 | 67,863 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,197,751 | 64,797 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $8,474,547 | 56,922 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $8,083,834 | 57,483 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,209,658 | 54,981 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||